How much is AdipoPharma worth in 2026?

AdipoPharma has a current valuation of $18.4M based on their Later Stage VC round and secondary market data.

How much funding has AdipoPharma raised?

AdipoPharma has raised $34.5M in total funding across 1 funding rounds.

AdipoPharma

Website

AdipoPharma valuation and funding history | Last updated: November 18, 2024 | 1 funding rounds

Current Valuation

$18.4M

As of November 18, 2024

Total Funding Raised

$34.5M

Across 1 round

Last Round

Later Stage VC

$9.4M

Last Funding

Nov 2024

Funding date

Capital Efficiency

0.53x

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
N/A	Unknown	Undisclosed	N/A	-

Valuation Analysis

Current Valuation Metrics

AdipoPharma is currently valued at $18.4M as of November 18, 2024. The company has raised a total of $34.5M in funding across 1 funding round.

Capital Efficiency

With a capital efficiency ratio of 0.53x, AdipoPharma has achieved a valuation that is 0.53 times the total capital raised.

Track AdipoPharma Valuation Updates

Get notified when AdipoPharma raises new funding or valuation changes

Explore More Data

Detailed analysis for AdipoPharma

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock AdipoPharma's valuation history, funding rounds, and growth metrics.

No credit card required

What is AdipoPharma Worth in 2026?

AdipoPharma is a leading private company in the technology sector. Track AdipoPharma's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How AdipoPharma Valuation is Determined

Private company valuations like AdipoPharma's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.